Kennedy R. Lees
University of Glasgow
467 Papers
3.9K Citations
Kennedy R. Lees is an academic researcher from University of Glasgow. The author has contributed to research in topics: Stroke & Medicine. The author has an hindex of 86, co-authored 455 publications. Previous affiliations of Kennedy R. Lees include Ludwig Maximilian University of Munich & Cedars-Sinai Medical Center.
Chat about Author
Papers
Response of Blood Pressure and Blood Glucose to Treatment With Recombinant Tissue-Type Plasminogen Activator in Acute Ischemic Stroke: Evidence From the Virtual International Stroke Trials Archive
Daniel M. Kerr,Rachael L. Fulton,Peter Higgins,Philip M.W. Bath,Ashfaq Shuaib,Patrick D. Lyden,Kennedy R. Lees +6 more
TL;DR: A stress response does not appear to be the principal cause of elevations in BP and glucose during stroke, and rtPA-treated patients were younger, less likely to have a history of hypertension or diabetes, and had more severe strokes on admission.
39
Effects of alteplase for acute stroke according to criteria defining the European Union and United States marketing authorizations: Individual-patient-data meta-analysis of randomized trials
Werner Hacke,Patrick D. Lyden,Jonathan Emberson,Jonathan Emberson,Colin Baigent,Colin Baigent,Lisa Blackwell,Lisa Blackwell,Gregory W. Albers,Erich Bluhmki,Thomas G. Brott,Geoffrey Cohen,Stephen M. Davis,Geoffrey A. Donnan,James C. Grotta,George Howard,George Howard,Markku Kaste,Masatoshi Koga,Rüdiger von Kummer,Rüdiger von Kummer,Maarten G Lansberg,Richard I. Lindley,Jean-Marc Olivot,Mark W Parsons,Peter Sandercock,Danilo Toni,Kazunori Toyoda,Nils Wahlgren,Joanna M. Wardlaw,William Whiteley,Gregory J. del Zoppo,Kennedy R. Lees,Kennedy R. Lees +33 more
TL;DR: The effects of alteplase in cohorts defined by the current Europe Union or United States marketing approval labels and by hypothetical revisions of the labels that would remove the Europe Union upper age limit or extend the United States treatment time window to 4.5 h were compared.
38
Prognostic value of single-photon emission tomography in acute ischaemic stroke.
Christopher J. Weir,Alison A. Bolster,Sharon Tytler,G. D. Murray,Rognvald S. Corrigall,Frederick G. Adams,Kennedy R. Lees +6 more
TL;DR: SPET provides useful information about the functional outcome of acute stroke at 1 year, however, the accuracy of prediction decreases the longer SPET is delayed, and predictive accuracy was better in patients who received SPET within 16 h of stroke onset.
37
Frequent Early Cardiac Complications Contribute to Worse Stroke Outcome in Atrial Fibrillation
Hans T.H. Tu,Bruce C.V. Campbell,Leonid Churilov,Jonathan M. Kalman,Kennedy R. Lees,Patrick D. Lyden,Ashfaq Shuaib,Geoffrey A. Donnan,Stephen M. Davis +8 more
TL;DR: The need for more rigorous surveillance for cardiac complications in acute ischemic stroke patients with AF is highlighted, as early SCAE are common after stroke and are independently associated with the presence of AF.
37